ALPHA TRIBE

Vista Pharmaceuticals LtdBoard Meeting, 14-08-2026: Board Meeting

14-08-2026 | 03:36 pm

Vista Pharma's Board approved Q1 results, showing a net loss of Rs. 0.99 Cr with Nil revenue. Facing significant 'going concern' doubts due to NPA and negative working capital, the company expects Rs. 9.22 Cr from warrant subscribers to support operations.

No comments yet. Be the first to comment!

All announcements from Vista Pharmaceuticals Ltd